High-Dose Cimetidine for the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group Study

    loading  Checking for direct PDF access through Ovid

Abstract

The Hoosier Oncology Group evaluated cimetidine in 42 patients with metastatic renal cell carcinoma. There were two complete remissions that lasted for 26 and 33+ months in 38 evaluable patients. There were no partial remissions. Toxicity was minimal. Patients with renal cell carcinoma can occasionally respond to cimetidine with long-term remission.

Related Topics

    loading  Loading Related Articles